Comprehensive geriatric assessment and frailty in transthyretin amyloid cardiomyopathy: toward more individualized and appropriate care
Netherlands Heart Journal · 09.11.2026
DOI: 10.1007/s12471-026-02097-9 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Netherlands Heart Journal, online erschienen am 09.11.2026. Verfasst von Sophie I van der Heide und 6 weiteren Autor:innen. Beteiligte Einrichtung: University Medical Center Utrecht, Department of Geriatrics, Utrecht University, Utrecht, The Netherlands. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Gerontologische Pflege
Abstract (Originalsprache)
Transthyretin amyloid cardiomyopathy (ATTR-CM), once considered a rare disease, is now an increasingly recognized cause of heart failure. This rise in diagnoses is driven by increased awareness, the availability of non-invasive diagnostics, and the introduction of disease-modifying therapies (DMTs) in an aging population. Available DMTs are costly and may require 12 to 18 months before clinical benefit becomes apparent, making careful assessment of expected treatment benefit essential. Because ATTR-CM predominantly affects older adults, frailty, multimorbidity, and competing health risks are common. Frailty is associated with poorer outcomes and reduced quality of life, yet is not captured by current prognostic staging systems, which primarily reflect cardiac disease severity. Frailty assessment may complement cardiac evaluation by supporting personalized DMT decision-making and identifying modifiable vulnerabilities for targeted interventions. This narrative review integrates cardiology and geriatric perspectives to examine the role of Comprehensive Geriatric Assessment, including frailty assessment, in ATTR-CM. Evidence on frailty prevalence, prognostic significance, and the concept of a disease-specific frailty phenotype is summarized. The role and key components of the CGA are outlined. Additionally, a multidisciplinary care pathway incorporating CGA into clinical practice is proposed to support personalized DMT decisions and targeted interventions.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- University Medical Center Utrecht, Department of Geriatrics, Utrecht University, Utrecht, The Netherlands.
- University Medical Center Utrecht, Department of Cardiology, Utrecht University, Utrecht, The Netherlands.
- University Medical Center Utrecht, Department of Geriatrics, Utrecht University, Utrecht, The Netherlands. w.knol@umcutrecht.nl.
ORCID-Profile: Sophie I van der Heide, A Clara Drenth-van Maanen, Geert J Lefeber, Mariëlle H Emmelot-Vonk, Manon G van der Meer, Marish I F J Oerlemans, Wilma Knol
Zitieren
APA
van der Heide, S. I., Drenth-van Maanen, A. C., Lefeber, G. J., Emmelot-Vonk, M. H., van der Meer, M. G., Oerlemans, M. I. F. J., & Knol, W. (2026). Comprehensive geriatric assessment and frailty in transthyretin amyloid cardiomyopathy: toward more individualized and appropriate care. Netherlands Heart Journal. https://doi.org/10.1007/s12471-026-02097-9
Vancouver
van der Heide SI, Drenth-van Maanen AC, Lefeber GJ, Emmelot-Vonk MH, van der Meer MG, Oerlemans MIFJ, et al. Comprehensive geriatric assessment and frailty in transthyretin amyloid cardiomyopathy: toward more individualized and appropriate care. Netherlands Heart Journal. 2026. doi:10.1007/s12471-026-02097-9
BibTeX
@article{vanderHeide2026,
author = {van der Heide, Sophie I and Drenth-van Maanen, A Clara and Lefeber, Geert J and Emmelot-Vonk, Mariëlle H and van der Meer, Manon G and Oerlemans, Marish I F J and Knol, Wilma},
title = {Comprehensive geriatric assessment and frailty in transthyretin amyloid cardiomyopathy: toward more individualized and appropriate care},
journal = {Netherlands Heart Journal},
year = {2026},
doi = {10.1007/s12471-026-02097-9}
}
EUVIMED